Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.

1. The effects of postnatal age and postnatal exposure to indomethacin on the pharmacokinetic parameters of ceftazidime (CAZ) were investigated in 23 preterm infants (gestational age 28.7 +/- 1.7 weeks; weight 1086 +/- 311 g) on day 3 and day 10 after birth. 2. CAZ (25 mg kg-1) was administered by intravenous bolus injection. Blood samples were drawn from an arterial catheter at 0, 0.5, 1, 2, 4, 8, and 12 h after the dose and CAZ concentrations in serum were determined by h.p.l.c. CAZ pharmacokinetics followed a one-compartment open model. 3. The glomerular filtration rate (GFR) of all infants was studied by means of the 24 h continuous inulin infusion technique. 4. The total body clearance of CAZ (34.7 +/- 9.2 vs 50.6 +/- 19.6 ml h-1, P < 0.05; 30.7 +/- 5.9 vs 41.6 +/- 9.0 ml h-1 kg-1, P < 0.05) and GFR (0.72 +/- 0.11 vs 0.91 +/- 0.15 ml min-1, P < 0.05) increased, whereas the apparent volume of distribution (425 +/- 147 vs 352 +/- 108 ml, P < 0.05; 363 +/- 59 vs 292 +/- 44 ml kg-1, P < 0.005) and the elimination half-life (8.7 +/- 2.8 vs 5.0 +/- 0.9 h, P < 0.005) decreased significantly between day 3 and day 10 after birth. Clearance of CAZ increased with increasing GFR (r = 0.81, P < 0.001). 5. In infants with postnatal exposure to indomethacin the changes in CAZ pharmacokinetics were markedly reduced. 6. These results indicate that the dosage regimen of CAZ should be adjusted after the first week of life except in infants who were postnatally exposed to indomethacin.

[1]  W. Hop,et al.  Effects of Prenatal Exposure to Betamethasone and Indomethacin on the Glomerular Filtration Rate in the Preterm Infant , 1994, Pediatric Research.

[2]  W. Hop,et al.  329 ONCE VERSUS TWICE DAILY DOSING OF CEFTAZIDIME IN THE PRETERM INFANT , 1994, Pediatric Research.

[3]  L. Storme,et al.  Pharmacokinetic study of piperacillin in newborns relating to gestational and postnatal age , 1992, The Pediatric infectious disease journal.

[4]  D. Knoppert,et al.  Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant , 1990, Antimicrobial Agents and Chemotherapy.

[5]  D. Stevenson,et al.  The use of antibiotics in neonates weighing less than 1200 grams. , 1990, The Pediatric infectious disease journal.

[6]  M. Coulthard,et al.  Maturation of glomerular filtration in preterm and mature babies. , 1985, Early human development.

[7]  A. Mulhall,et al.  Ceftazidime in neonatal infections. , 1985, Archives of disease in childhood.

[8]  W. Zijlstra,et al.  Composition of Postnatal Weight Loss and Subsequent Weight Gain in Small for Dates Newborn Infants , 1985, Acta paediatrica Scandinavica.

[9]  G. Mccracken,et al.  Pharmacokinetics of ceftazidime in newborn infants , 1984, Antimicrobial Agents and Chemotherapy.

[10]  G. Haycock,et al.  Sodium homeostasis in term and preterm neonates. III. Effect of salt supplementation. , 1984, Archives of disease in childhood.

[11]  B. Assael,et al.  Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration , 1983, Antimicrobial Agents and Chemotherapy.

[12]  G. Haycock,et al.  Sodium homeostasis in term and preterm neonates. I. Renal aspects. , 1983, Archives of disease in childhood.

[13]  B. Haneberg,et al.  CLINICAL ASSESSMENT OF GESTATIONAL AGE IN THE NEWBORN INFANT , 1981, Acta paediatrica Scandinavica.

[14]  A. Aperia,et al.  POSTNATAL DEVELOPMENT OF RENAL FUNCTION IN PRE‐TERM AND FULL‐TERM INFANTS , 1981, Acta paediatrica Scandinavica.

[15]  C. Fawer,et al.  Maturation of renal function in full-term and premature neonates. , 1979, Helvetica paediatrica acta.

[16]  B. Arant,et al.  Developmental patterns of renal functional maturation compared in the human neonate. , 1978, The Journal of pediatrics.

[17]  W. Oh,et al.  Inulin Clearance in the Newborn Infant: Relationship to Gestational and Postnatal Age , 1976, Pediatric Research.

[18]  L. Nelin,et al.  Relationship between nutrition, weight change, and fluid compartments in preterm infants during the first week of life. , 1993, The Journal of pediatrics.

[19]  J. N. van den Anker,et al.  Use of antibiotics in neonates weighing less than 1200 g. , 1990, The Pediatric infectious disease journal.

[20]  P. Chrétien,et al.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn. , 1989, Diagnostic microbiology and infectious disease.

[21]  A. Mulhall,et al.  The pharmacokinetics and safety of ceftazidime in the neonate. , 1985, The Journal of antimicrobial chemotherapy.

[22]  J. Moncrieff,et al.  A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants. , 1983, The Journal of antimicrobial chemotherapy.

[23]  J. Ayrton Assay of ceftazidime in biological fluids using high-pressure liquid chromatography. , 1981, The Journal of antimicrobial chemotherapy.